BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32536235)

  • 1. Arsenic trioxide and all-trans retinoic acid suppress the expression of FLT3-ITD.
    Liang C; Peng CJ; Wang LN; Li Y; Zheng LM; Fan Z; Huang DP; Tang WY; Zhang XL; Huang LB; Tang YL; Luo XQ
    Leuk Lymphoma; 2020 Nov; 61(11):2692-2699. PubMed ID: 32536235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways.
    Wang LN; Tang YL; Zhang YC; Zhang ZH; Liu XJ; Ke ZY; Li Y; Tan HZ; Huang LB; Luo XQ
    Leuk Lymphoma; 2017 Oct; 58(10):2426-2438. PubMed ID: 28276286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential Transcriptomic and Metabolomic Mechanisms of ATO and ATRA in Treatment of FLT3-ITD Acute Myeloid Leukemia.
    Peng CJ; Fan Z; Luo JS; Wang LN; Li Y; Liang C; Zhang XL; Luo XQ; Huang LB; Tang YL
    Technol Cancer Res Treat; 2024; 23():15330338231223080. PubMed ID: 38179723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-trans Retinoic Acid, Arsenic Trioxide, and Anthracycline-based Chemotherapy Improves Outcome in Newly Diagnosed Acute Promyelocytic Leukemia Regardless of FLT3-ITD Mutation Status.
    Xu LW; Su YZ; Tao HF
    Curr Med Sci; 2021 Jun; 41(3):491-497. PubMed ID: 34169421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia.
    Jebanesan DZP; Illangeswaran RSS; Rajamani BM; Vidhyadharan RT; Das S; Bijukumar NK; Balakrishnan B; Mathews V; Velayudhan SR; Balasubramanian P
    Ann Hematol; 2024 Jun; 103(6):1919-1929. PubMed ID: 38630133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo.
    Ma HS; Greenblatt SM; Shirley CM; Duffield AS; Bruner JK; Li L; Nguyen B; Jung E; Aplan PD; Ghiaur G; Jones RJ; Small D
    Blood; 2016 Jun; 127(23):2867-78. PubMed ID: 27103744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-trans retinoic acid exerts selective anti-FLT3-ITD acute myeloid leukemia efficacy through downregulating Chk1 kinase.
    Wang W; Jiang Z; Wang L; Wang A; Liu J; Chen C; Yu K; Zou F; Wang W; Liu J; Liu Q
    Cancer Lett; 2020 Mar; 473():130-138. PubMed ID: 31904486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.
    Cicconi L; Divona M; Ciardi C; Ottone T; Ferrantini A; Lavorgna S; Alfonso V; Paoloni F; Piciocchi A; Avvisati G; Ferrara F; Di Bona E; Albano F; Breccia M; Cerqui E; Sborgia M; Kropp MG; Santoro A; Levis A; Sica S; Amadori S; Voso MT; Mandelli F; Lo-Coco F
    Leukemia; 2016 Oct; 30(10):1987-1992. PubMed ID: 27133819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells.
    Wang R; Li Y; Gong P; Gabrilove J; Waxman S; Jing Y
    Mol Cancer Ther; 2018 Sep; 17(9):1871-1880. PubMed ID: 29959200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of endoplasmic reticulum stress induced by all-trans retinoic acid on apoptosis of FLT3-ITD mutated leukemia cells by activating autophagy in FLT3-ITD mutated protein].
    Zheng LM; Wang LN; Liang C; Peng CJ; Tang WY; Zhang XL; Li Y; Tang YL; Huang LB; Luo XQ
    Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):836-842. PubMed ID: 33190441
    [No Abstract]   [Full Text] [Related]  

  • 11. Arsenic trioxide induces autophagic degradation of the FLT3-ITD mutated protein in FLT3-ITD acute myeloid leukemia cells.
    Liu XJ; Wang LN; Zhang ZH; Liang C; Li Y; Luo JS; Peng CJ; Zhang XL; Ke ZY; Huang LB; Tang YL; Luo XQ
    J Cancer; 2020; 11(12):3476-3482. PubMed ID: 32284743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of arsenic trioxide and flt3 inhibition on cells with flt3 internal tandem duplication.
    Takahashi S; Harigae H; Yokoyama H; Ishikawa I; Abe S; Imaizumi M; Sasaki T; Kaku M
    Int J Hematol; 2006 Oct; 84(3):256-61. PubMed ID: 17050201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib plus all-trans retinoic acid for AML patients with FLT3-ITD and NPM1 mutations.
    Guenounou S; Delabesse E; Récher C
    Eur J Haematol; 2014 Dec; 93(6):533-6. PubMed ID: 24689895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-occurrence of PML-RARA gene fusion, chromosome 8 trisomy, and FLT3 ITD mutation in a young female patient with de novo acute myeloid leukemia and early death: A CARE case report.
    Tripon F; Crauciuc GA; Bogliş A; Moldovan V; Sándor-Kéri J; Benedek IJ; Trifa AP; Bănescu C
    Medicine (Baltimore); 2020 Apr; 99(14):e19730. PubMed ID: 32243411
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Esnault C; Rahmé R; Rice KL; Berthier C; Gaillard C; Quentin S; Maubert AL; Kogan S; de Thé H
    Blood; 2019 Mar; 133(13):1495-1506. PubMed ID: 30674471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATRA can enhance apoptosis that is induced by Flt3 tyrosine kinase inhibition in Flt3-ITD positive cells.
    Scholl S; Müller R; Clement JH; Loncarevic IF; Böhmer FD; Höffken K
    Leuk Res; 2006 May; 30(5):633-42. PubMed ID: 16473406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3.
    Lu H; Weng XQ; Sheng Y; Wu J; Xi HM; Cai X
    BMC Cancer; 2022 Jul; 22(1):749. PubMed ID: 35810308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Dihydroartemisinin and Arsenic Trioxide on Apoptosis of Acute Myeloid Leukemia Cells].
    Sun WD; Wang X; Wang Y; Tong XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1337-1342. PubMed ID: 36208232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML.
    Masciarelli S; Capuano E; Ottone T; Divona M; Lavorgna S; Liccardo F; Śniegocka M; Travaglini S; Noguera NI; Picardi A; Petrozza V; Fatica A; Tamagnone L; Voso MT; Lo Coco F; Fazi F
    Blood Adv; 2019 Dec; 3(24):4155-4160. PubMed ID: 31834935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between
    Vu MP; Nguyen CN; Vu H; Nguyen TM; Nguyen TT; Pham PT
    J Int Med Res; 2022 Dec; 50(12):3000605221138490. PubMed ID: 36539954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.